China Shineway Pharmaceutical Group Limited (2877.HK) HKSE
8.61
+0.01(+0.12%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.84B |
| Enterprise Value | -1.02B |
| P/E Ratio | 5.83 |
| PEG Ratio | 0.46 |
| Price/Sales Ratio | 1.77 |
| Price/Book Ratio | 0.69 |
| Enterprise/Revenue | -0.42 |
| Enterprise/EBITDA | -1.78 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.3 |
| Operating Margin | 0.22 |
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 3.14B |
| Revenue/Share | 4.15 |
| Gross Profit | 2.27B |
| EBITDA | 739.53M |
| Net Income | 949.95M |
| Diluted EPS | 1.26 |
Balance Sheet
| Total Cash | 7.57B |
| Total Cash/Share | 10.02 |
| Total Debt | 335.05M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 3.71 |
| Book Value Per Share | 10.68 |
Price History
| 52-Week Change | 14.09 |
| 52-Week High | 10.47 |
| 52-Week Low | 7.4 |
| Moving Average 50 Days | 9.29 |
| Moving Average 200 Days | 8.98 |
Statistics
| Average Volume | 1.14M |
| Shares Outstanding | 755.4M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.52 |
| Trailing Annual Dividend Yield | 7.14 |
| Payout Ratio | 0.38 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
